Activation of nitric oxide synthesis in vascular smooth muscle cells and macrophages during development in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 9, Issue 4 I, 1996, Pages 377-384

  Xiao, Jin ^a   Pang, Peter K T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

hypertension; lymphocytes; nitric oxide; vascular smooth muscle cells

Indexed keywords

NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERTENSION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029869225     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00388-6     Document Type: Article

References (38)

1. Rowland M, Robert J: Center for Health Statistics No. 84. National Center for Health Statistics of the Nation, United States Department of Health and Human Services, Washington, DC, 1982.
2. Dzielak DJ: Immune mechanisms in experimental and essential hypertension. Am J Physiol 1991;260:R459-R467.
3. Takeichi N, Suzuki K, Okayasu T, et al: Immunological depression in spontaneously hypertensive rats. Clin Exp Immunol 1980;40:120-126.
4. Pascual VH, Oparil S, Eldridge JH, et al: Spontaneously hypertensive rat: lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation. Am J Physiol 1992;262:R1-R7.
5. Ba D, Takeichi N, Kodama T, et al: Restoration of T-cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J Immunol 1982;128:1211-1216.
6. Khraibi AA, Norman RA, Dzielek DJ: Chronic immunosuppression attenuates hypertension in Okamoto spontaneously hypertensive rats. Am J Physiol 1984;247:H722-726.
7. Fannon LD, Braylan RC, Phillips MI: Alteration of lymphocyte populations during development in the spontaneously hypertensive rat. J Hypertens 1992;10:629-634.
8. Hilme E, Hansson L, Sandberg L, et al: Abnormal immune functions in malignant hypertension. J Hypertens 1993;11:989-994.
9. Xiao J, Zeng Y, Pang PKT: Involvement of nitric oxide in the blastogenic response deficiency in splenocytes from spontaneously hypertensive rats. Am J Hypertens 1993;6:241-247.
10. Pascual DW, Pascual VH, Bost KL, et al: Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat. Hypertension 1993;21:185-194.
11. Xiao J, Pang PKT: Does a general alteration in the nitric oxide system occur in spontaneously hypertensive rats? Am J Physiol 1994;266:H272-H278.
12. Mills CD: Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 1991;146:2719-2723.
13. Pang PKT, Wang R, Shan J, et al: Specific inhibition of long-lasting L-type calcium channels by synthetic parathyroid hormone. Proc Natl Acad Sci USA 1990;87:623-627.
14. Rao GN, Berk BC: Active oxygen species stimulated vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992;70:593-599.
15. Hibbs JB, Taintor RR, Vavrin Z: Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987;235:473-476.
16. 15N] nitrate in biologic fluids. Anal Biochem 1982;126:131-138.
17. Junquero DC, Schini VB, Scott-Burden T, et al: Transforming growth factor-beta 1 inhibits L-arginine-derived relaxing factor(s) from smooth muscle cells. Am J Physiol 1992;262:H1788-H1795.
18. Xie Q, Cho JH, Calaycay J, et al: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256:225-228.
19. Nunokawa Y, Ishida N, Tanaka S: Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1993;191:89-94.
20. Geller DA, Nussler AK, Silvio AD, et al: Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993;90:522-526.
21. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-141.
22. Ignarro LJ: Physiological significance of endogenous nitric oxide. Semin Perinatol 1991;15:20-26.
23. Lockette W, Otsuka Y, Carretero O: The loss of endothelium-dependent relaxation in hypertension. Hypertension 1986;8(suppl II):II61-II66.
24. Panza JA, Casino PR, Kilcoyne CM, et al: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-1474.
25. Malinski T, Kapturczak M, Dayharsh J, et al: Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 1993;194:654-658.
26. Ito S, Carretero OA: Impaired response to acetylcholine despite intact endothelium-derived relaxing factor / nitric oxide in isolated microperfused afferent arterioles. J Cardiovasc Pharmacol 1992;20(suppl 12):s187-s189.
27. Li J, Bukoshi RD: Endothelium-dependent relaxation of hypertensive resistance arteries is not impaired under all conditions. Circ Res 1993;72:290-296.
28. Lee L, Webb RC: Endothelium-dependent relaxation and L-arginine metabolism in genetic hypertension. Hypertension 1992;19:435-441.
29. G-Nitro arginine produces an exaggerated hypertension in anaesthetized SHR. Eur J Pharmacol 1991;197:239-240.
30. Kubaszewski E, Peters A, McClain S, et al: Light-activated release of nitric oxide from vascular smooth muscle of normotensive and hypertensive rats. Biochem Biophys Res Commun 1994;200:213-218.
31. Mulvany MJ: Vascular structure and smooth muscle contractility in experimental hypertension. J Cardiovasc Pharmacol 1987;10(suppl 6):s79-s85.
32. Ferrier C, Jennings GL, Eisenhofer G, et al: Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 1993;11:1217-1227.
33. Bradshaw B, Moore TJ: Abnormal regulation of adrenal angiotensin II receptors in spontaneously hypertensive rats. Hypertension 1988;11:49-54.
34. Naruse M, Kawana M, Hifumi S, et al: Plasma immunoreactive endothelin but not thromobulin, is increased in patients with essential hypertension and ischemic heart disease. J Cardiovasc Pharmacol 1991;17(suppl 7):s471-s474.
35. 2 are contractile factors in intrarenal arteries of spontaneously hypertensive rats. Hypertension 1992;19:795-798.
36. Shepherd JT, Katušić ZS: Endothelium-derived vasoactive factors. I. Endothelium-dependent relaxation. Hypertension 1991;18(suppl III):III76-III85.
37. Junquero DC, Schini VB, Scott-Burden T, et al: Enhanced production of nitric oxide in aortae from spontaneously hypertensive rats by interleukin-1 β. Am J Hypertens 1993;6:602-610.
38. Mourlon-Le Grand MC, Benessiano J, Levy BI: cGMP pathway and mechanical properties of carotid artery wall in WKY and SHR: role of endothelium. Am J Physiol 1992;263:H61-H67.